135 related articles for article (PubMed ID: 16360114)
1. Heterologous expression, purification, and properties of human cytochrome P450 27C1.
Wu ZL; Bartleson CJ; Ham AJ; Guengerich FP
Arch Biochem Biophys; 2006 Jan; 445(1):138-46. PubMed ID: 16360114
[TBL] [Abstract][Full Text] [Related]
2. A tricistronic human adrenodoxin reductase-adrenodoxin-cytochrome P450 27A1 vector system for substrate hydroxylation in Escherichia coli.
Salamanca-Pinzón SG; Guengerich FP
Protein Expr Purif; 2011 Oct; 79(2):231-6. PubMed ID: 21621619
[TBL] [Abstract][Full Text] [Related]
3. Binding of cytochrome P450 27C1, a retinoid desaturase, to its accessory protein adrenodoxin.
Glass SM; Webb SN; Guengerich FP
Arch Biochem Biophys; 2021 Dec; 714():109076. PubMed ID: 34732331
[TBL] [Abstract][Full Text] [Related]
4. Human mitochondrial cytochrome P450 27C1 is localized in skin and preferentially desaturates
Johnson KM; Phan TTN; Albertolle ME; Guengerich FP
J Biol Chem; 2017 Aug; 292(33):13672-13687. PubMed ID: 28701464
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
6. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
Sandhu P; Baba T; Guengerich FP
Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
[TBL] [Abstract][Full Text] [Related]
7. Comparative structural-functional characterization of recombinant and natural adrenodoxin. Interaction with cytochrome P450scc.
Lepesheva GI; Azeva TN; Strushkevich NV; Adamovich TB; Cherkesova TS; Usanov SA
Biochemistry (Mosc); 1999 Sep; 64(9):1079-88. PubMed ID: 10521726
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cytochrome P450 CYP109E1 from Bacillus megaterium as a novel vitamin D
Abdulmughni A; Jóźwik IK; Putkaradze N; Brill E; Zapp J; Thunnissen AW; Hannemann F; Bernhardt R
J Biotechnol; 2017 Feb; 243():38-47. PubMed ID: 28043840
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions of adrenodoxin with several human mitochondrial cytochrome P450 enzymes.
Child SA; Reddish MJ; Glass SM; Goldfarb MH; Barckhausen IR; Guengerich FP
Arch Biochem Biophys; 2020 Nov; 694():108596. PubMed ID: 32980349
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1.
Araya Z; Hosseinpour F; Bodin K; Wikvall K
Biochim Biophys Acta; 2003 Jun; 1632(1-3):40-7. PubMed ID: 12782149
[TBL] [Abstract][Full Text] [Related]
11. Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties.
Gillam EM; Guo Z; Guengerich FP
Arch Biochem Biophys; 1994 Jul; 312(1):59-66. PubMed ID: 8031147
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27).
Pikuleva IA; Björkhem I; Waterman MR
Arch Biochem Biophys; 1997 Jul; 343(1):123-30. PubMed ID: 9210654
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
15. Identification of retained N-formylmethionine in bacterial recombinant mammalian cytochrome P450 proteins with the N-terminal sequence MALLLAVFL...: roles of residues 3-5 in retention and membrane topology.
Dong MS; Bell LC; Guo Z; Phillips DR; Blair IA; Guengerich FP
Biochemistry; 1996 Aug; 35(31):10031-40. PubMed ID: 8756465
[TBL] [Abstract][Full Text] [Related]
16. Rabbit liver cytochrome P-450 2B5: high-level expression of the full-length protein in Escherichia coli, purification, and catalytic activity.
Lehnerer M; Schulze J; Petzold A; Bernhardt R; Hlavica P
Biochim Biophys Acta; 1995 Aug; 1245(1):107-15. PubMed ID: 7654758
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
[TBL] [Abstract][Full Text] [Related]
18. Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1.
Wu ZL; Sohl CD; Shimada T; Guengerich FP
Mol Pharmacol; 2006 Jun; 69(6):2007-14. PubMed ID: 16551781
[TBL] [Abstract][Full Text] [Related]
19. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
[TBL] [Abstract][Full Text] [Related]
20. [Crystallization of a covalently-linked complex of adrenodoxin and adrenodoxin reductase].
Lapko AG; Rukpaul' K
Biokhimiia; 1996 Sep; 61(9):1637-47. PubMed ID: 8998287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
